Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
An artist's rendering of poop pills. So close, yet so far.
Marc Bruxelle / Getty Images
Seres Therapeutics, a pioneer in the race to develop therapeutic pills from poop, has suffered a key setback with a drug failing to pass clinical trials.The results co…